Diabetes

Sitagliptin Tied to Improved Outcomes among Diabetics with COVID-19

October 01, 2020

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

Exposure to Diabetes in the Womb Could Increase Heart Disease Risk

September 30, 2020

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

UVA Study Suggests NRTIs Could Reduce Risk of Developing Type 2 Diabetes

September 29, 2020

An analysis of data from 5 major databases suggests NRTIs could reduce incidence of type 2 diabetes.

David Cherney, MD: SGLT2 Inhibitors and Prescribing Responsibility

September 28, 2020

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics

September 25, 2020

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Metformin Could Slow Cognitive Decline, Reduce Dementia Incidence in Diabetics

September 24, 2020

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics

September 23, 2020

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes

September 23, 2020

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

Diabetics, Both Type 1 and Type 2, at Increased Risk of Falls, Fall-Related Injuries

September 22, 2020

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

Rheumatoid Arthritis Tied to 23% Increase in Risk of New Diabetes

September 22, 2020

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

Pediatric Asthma Treatment Could Increase Risk of Diabetes, Other Conditions

September 18, 2020

New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.

Feelings of Loneliness in Older Adults Tied to Increase Risk of New-Onset Diabetes

September 16, 2020

Analysis of data from a European aging study suggests feeling lonely was linked to an increased risk of developing diabetes in older adults.

Gestational Diabetes Linked to Accelerated Aging in Offspring

September 15, 2020

An analysis of more than 1100 children suggests those born to mothers with gestational diabetes mellitus were at increased risk of accelerated aging.

Matthew Budoff, MD: Clinical Usefulness of CAC Scores

September 11, 2020

An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.

Cardiometabolic Health Fellowships: The Answer or Part of the Problem?

September 06, 2020

Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.

CV Benefit of Dulaglutide Present Regardless of Background Metformin Use

September 05, 2020

An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.

DAPA-CKD Details Effects of Dapagliflozin on CKD in Diabetics and Nondiabetics

September 04, 2020

Full results of DAPA-CKD further inform clinicians on dapagliflozin and use of SGLT2 inhibitors in those with and without diabetes.

Galectin-3 Plasma Levels Help Predict Cardiovascular Events in Diabetics

September 03, 2020

An ESC Congress 2020 study details the predictive value of galectin-3 levels for predicting risk of cardiovascular events in patients with type 2 diabetes

Prof. Heerspink: DAPA-CKD and Use of Dapagliflozin

September 03, 2020

A podcast featuring the presenter of DAPA-CKD discussing results of the trial and how they inform use of dapagliflozin in patients with chronic kidney disease with and without type 2 diabetes.

Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients

September 02, 2020

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.